Saskia Hendriks, MD, PhD

BS, Amsterdam University College
MD, University of Amsterdam
PhD, Faculty of Medicine, University of Amsterdam

Dr. Hendriks is a faculty member in the NIH Department of Bioethics. She focuses on research ethics and the ethical, social and legal implications of emerging medical technologies, primarily within neuroscience and reproduction. Dr. Hendriks conducts theoretical/conceptual bioethics research. She also does interview and survey studies understand views of patients, professionals, and the general public on topics related to bioethics.

Dr. Hendriks has a joint appointment in the Neuroethics Program of the National Institute of Neurological Disorders and Stroke, where she serves as a faculty neuroethics consultant.

Curriculum Vitae

• NINDS Director's Award. For conceptualizing and launching the Neuroethics Consultation Service (with Dr. Khara Ramos), 2020
• NINDS Director's Award. For reestablishing and revitalizing a cross-cutting group focused on the intersection of data science and neuroscience in extramural NINDS (group award, 7 other awardees), 2020
• Residency at Brocher Foundation, 2016

Hendriks S, Li X, Grady C, Kim, SYH. Public views on whether the use of pharmaceutical neuroenhancements should be allowed. Neurology, 2024;103(4):e209681.

Hendriks S, Grady C. Ethics and Highly Innovative Research on Brain Diseases. New England Journal of Medicine, 2024;390:2133-2136.

Hendriks S, Althaus J, Atkinson MA, Baschat AA, Berkman BE, Grady C, Wasserman D, Wendler D, Miller JL. Precarious hope: ethical considerations for offering experimental fetal therapies outside of research after initial studies in humans. Prenatal Diagnosis. 2024: 44(2):180-186.

Hendriks S*, Hsu N*, Beckel-Mitchener AC, Ngai J, Grady C. Continuing trial responsibilities for implantable neural devices. Neuron. 2023: 111(20):3143-3149.

Hendriks S, Grady C, Ramos KM. Survey of Investigators About Sharing Human Research Data in the Neurosciences. Neurology 2022, 99 (12) e1314-e1325.

Hendriks S, Grady C, Wasserman D, Wendler D, Bianchi DW, Berkman B. A new ethical framework to determine acceptable risks in fetal therapy trials. Prenatal Diagnosis 2022; 42(8):962-969.

Hendriks S, Grady C, Wasserman D, Wendler D, Bianchi DW, Berkman B. A new ethical framework for assessing the unique challenges of fetal therapy trials. The American Journal of Bioethics, 2022;22(3):45-61.

Hsu N*, Hendriks S*, Ramos KM, Grady C. COVID-related adjustments to clinical research: ethical considerations for investigators. Nature Medicine 2021;27,191–193.

Iyer AA, Saade D, Bharucha-Goebel DX, Foley AR, Averion G, Paredes E, Gray S, Bonnemann CG, Grady C, Hendriks S, Rid A. Ethical challenges Ethical Challenges for a New Wave of Early-Phase Pediatric Gene Therapy Trials. Genetics in Medicine, 2021;23(11): 2057-2066.

Hendriks S, Pearson SD. Assessing potential cures: are there distinctive elements of value beyond health gain? Journal of Comparative Effectiveness Research, 2021;10(4):255–65.

Hendriks S*, Grady C*, Ramos KM, Chiong W, Fins JJ, Ford P, Goering S, Greely HT, Hutchison K, Kelly ML, Kim SYH, Klein E, Lisanby SH, Mayberg H, Maslen H, Miller FG, Rommelfanger K, Sheth SA, Wexler A. Ethical Challenges of Risk, Informed Consent, and Posttrial Responsibilities in Human Research With Neural Devices: A Review. JAMA Neurology, 2019;76(12):1506–1514.

* shared first authorship